000 | 01146 a2200337 4500 | ||
---|---|---|---|
005 | 20250516200632.0 | ||
264 | 0 | _c20150218 | |
008 | 201502s 0 0 eng d | ||
022 | _a1468-3288 | ||
024 | 7 |
_a10.1136/gutjnl-2014-306746 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _avan Bodegraven, Ad A | |
245 | 0 | 0 |
_aAuthors' response: The role of risedronate in osteopenia in Crohn's disease. _h[electronic resource] |
260 |
_bGut _cJan 2015 |
||
300 |
_a185-6 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 |
_aBone Density Conservation Agents _xtherapeutic use |
650 | 0 | 4 |
_aBone Diseases, Metabolic _xdrug therapy |
650 | 0 | 4 |
_aCalcium _xtherapeutic use |
650 | 0 | 4 |
_aCrohn Disease _xcomplications |
650 | 0 | 4 | _aDietary Supplements |
650 | 0 | 4 |
_aEtidronic Acid _xanalogs & derivatives |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aVitamin D _xtherapeutic use |
700 | 1 | _aWitte, Birgit I | |
700 | 1 | _aLips, Paul | |
773 | 0 |
_tGut _gvol. 64 _gno. 1 _gp. 185-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/gutjnl-2014-306746 _zAvailable from publisher's website |
999 |
_c23585381 _d23585381 |